Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN
Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is up...
Trading A Bottom in Small Cap Life Science Stocks …Update 11/5
11/15/14 Speculative Small Cap Stocks-Stay Away Unless Your Are A Trader Nice profits were booked on our recent small cap picks but today the sell-off was "pronounced": Celldex (CLDX) was down 21% to $13.10 after hitting a high near $18 on October 31. GlycoMimetics (GLYC) was up 2.14% to $7.62...
Technical Damage to Market is Significant: Fear Factor Rules..Update 10/14
10/14 ...Update 3:10p Here come the sellers late in the day on schedule. Investors are trying to hold the fort. Oil down, treasuries up, JPMorgan misses off 0.43%. XLE off 0.57%, Gold steady at 1233, biotechs mixed but GILD down 5%, industrials and technology in the green. Germany slashes...
BIO Investor Forum Oct. 7-8, 2014: #1 How Fragile is the Biotech Rally?
Five Year Bull Market in Biotech We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio Investor Forum is one of...
No Follow-Through Rally From Jobs Report: Small Caps Still Weak
NASDAQ Slides After Good Opening -Down 0.47% The enthusiasm generated by Friday's jobs report waned after the opening. The shocking 92% decline in shares of GT Advanced Technologies , Inc.(GTAT) due to a bankruptcy filing rattled traders and drove small cap stocks down again near 2014 lows....